Category: Kips Bay Medical Inc.
Kips Bay reports widening losses and shrinking sales for its 4th quarter, but the FDA's decision to allow full enrollment in the U.S. arm of the company's feasibility trial is an important turnaround for the device maker.
Medical device maker Kips Bay Medical (NSDQ:KIPS) saw widening losses and sinking sales during its most recent quarter, but the company marked an important win with FDA approval to complete full enrollment in the U.S. arm of a feasibility study.
Cardiovascular Systems prices an offering of 2 million shares at $17.60 apiece, saying it expects to net about $33 million from the deal for "working capital and general corporate purposes," likely including its ORBIT II atherectomy trial.
Cardiovascular Systems (NSDQ:CSII) priced a public offering of some 2 million shares of CSII stock at $17.60 apiece, saying it expects to net about $33 million from the deal.
Holaira says it raised $10 million from existing investors for its lung denervation system to treat chronic obstructive pulmonary disease.
Medical device company Holaira said it drummed up $10 million, changed its name and moved its headquarters.
Formerly known as Innovative Pulmonary Solutions, Holaira said it plans to use the Series C round to develop its minimally invasive devices to treat obstructive lung disease. All of Holaira's existing backers participated, namely Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, and Versant Ventures.
Echo Therapeutics aims to raise some $10 million from a public offering of 10.3 million shares of stock at 75¢ apiece.
Echo Therapeutics (NSDQ:ECTE) priced its public stock offering at 75¢ per share, saying it expects to raise about $10 million in gross proceeds.
The 13.3 million-share offering includes a 45-day over-allotment option for bookrunner Aegis Capital for another 2 million shares.
Kips Bay medical issues an additional 10,000,000 shares of its common stock for $6.5 million, seeking FDA approval for its saphenous vein graft.
Minneapolis-based device maker Kips Bay Medical (NSDQ:KIPS) closed its $6.5 million public offering of 10,000,000 shares of its common stock, hoping to use the funds to seek regulatory approval for its eSVS Mesh system worldwide.
Medical device company Mako Surgical prices a more than 3-million-share stock offering worth $40 million.
Mako Surgical (NSDQ:MAKO) priced a stock offering of more than 3 million shares at $13.15 apiece, raising some $40 million in total.
The FDA awards conditional IDE approval to Kips Bay Medical, allowing the company to begin a clinical study of its eSVS mesh in coronary artery bypass graft surgery.
Kips Bay Medical (NSDQ:KIPS) won conditional FDA investigational device exemption approval for its eSVS mesh, allowing the company to begin a clinical study of the device in use during coronary artery bypass procedures.